Intravascular Lithotripsy
33 places
Worldwide report
Every place
- 33Reports naming them
- 1Markets they lead in
- 33Regions & countries
- 7Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Shockwave Medical (Johnson & Johnson) or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Where they show up
33 reportsOur reports that name Shockwave Medical (Johnson & Johnson) as a key player, by category and place.
- Medical Devices · 33
Places 33
- Africa 1
- APAC 1
- Australia 1
- Brazil 1
- Canada 1
- China 1
- Ecuador 1
- Egypt 1
- Europe 1
France 1- Germany 1
- Global 1
Hong Kong 1
India 1
Italy 1
Japan 1
Kenya 1- Latin America 1
Malaysia 1
Mexico 1- Middle East 1
New Zealand 1- North America 1
Philippines 1
Russia 1
Saudi Arabia 1
Singapore 1
South Africa 1
Spain 1
Thailand 1- UAE 1
UK 1
US 1
Shockwave Medical (Johnson & Johnson)'s markets
1Markets where they are a key player. Each opens the market's statistics for every place we cover.
Medical Devices1
None of their markets match.
Recent reports naming Shockwave Medical (Johnson & Johnson)
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
33 places
Companies they compete with most
Named as key players in the same markets as Shockwave Medical (Johnson & Johnson) (number of shared markets).
Abbott Laboratories1 shared market
Amplitude Vascular1 shared market
Boston Scientific Corporation1 shared market
FastWave Medical1 shared market
Boston Scientific Corporation1 shared market
FastWave Medical1 shared market
Free public data on Shockwave Medical (Johnson & Johnson)
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Clinical trials
7 active studies led by Shockwave Medical (Johnson & Johnson), of 28 in all
Source: ClinicalTrials.gov, Studies with Shockwave Medical (Johnson & Johnson) (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
US device clearances
14 510(k) clearances and PMA approvals since 2015
- Shockwave Intravascular Lithotripsy (Ivl) System With Shockwave C2 Coronary Int… P200039 · 11 Sep 2026
- Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher… K262201 · 27 Jul 2026
- Shockwave Cs Guide Catheter K243757 · 2 May 2025
- Shockwave Intravascular Lithotripsy (Ivl) System With The Javelin Peripheral In… K242213 · 27 Sep 2024
- Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave L6 Peripher… K240954 · 7 May 2024
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Trials over time
Studies Shockwave Medical (Johnson & Johnson) leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Shockwave Medical (Johnson & Johnson) or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Topics
The topics of the markets Shockwave Medical (Johnson & Johnson) is in.
From our blog
Stories on the topics Shockwave Medical (Johnson & Johnson) works in.
Omega-3: Heart, Brain and the Evidence Debate
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
Angiography: Seeing Inside the Blood Vessels
Cardiovascular disease is the world's leading cause of death, and stroke caused 11.9 million new cases in…
Read
Angioplasty Balloons and Heart Care in India
In 2017 India capped coronary stent prices, cutting drug-eluting stent prices by about 85%. Heart disease is…
ReadSearch all reports for Shockwave Medical (Johnson & Johnson) All companies